Razi Journal of Medical Sciences
مجله علوم پزشکی رازی
RJMS
Medical Sciences
http://rjms.iums.ac.ir
39
journal39
2228-7043
2228-7051
en
jalali
1391
11
1
gregorian
2013
2
1
19
104
online
1
fulltext
fa
تعیین درصد فراوانی استفاده از پروفیلاکسی علیه ترومبوز وریدهای عمقی در بیماران بستری در بخش های جراحی بیمارستان حضرت رسول اکرم(ص)
Determination of the frequency of prophylaxis usage against deep-vein thrombosis in hospitalized patients admitted in an educational hospital
جراحی عمومی
General Surgery
پژوهشي
Research
<font face="Times New Roman" size="3"> </font><p class="MsoNormal" style="margin: 0in 0in 0pt text-align: justify line-height: normal unicode-bidi: embed direction: rtl text-justify: kashida text-kashida: 0%" dir="rtl"><b><span lang="FA" style="font-family: "B Mitra" font-size: 10pt mso-bidi-language: FA mso-ascii-font-family: "Times New Roman" mso-hansi-font-family: "Times New Roman" mso-ansi-font-size: 9.0pt">زمینه و هدف</span></b><span lang="FA" style="font-family: "B Mitra" font-size: 10pt mso-bidi-language: FA mso-ascii-font-family: "Times New Roman" mso-hansi-font-family: "Times New Roman" mso-ansi-font-size: 9.0pt">: عدم تشخیص و درمان ترومبوز وریدی عمقی (</span><span style="font-family: "Times New Roman","serif" font-size: 9pt mso-bidi-language: FA mso-bidi-font-size: 10.0pt mso-bidi-font-family: "B Mitra"" dir="ltr">DVT= Deep Vein Thrombosis</span><span dir="rtl"></span><span lang="FA" style="font-family: "B Mitra" font-size: 10pt mso-bidi-language: FA mso-ascii-font-family: "Times New Roman" mso-hansi-font-family: "Times New Roman" mso-ansi-font-size: 9.0pt"><span dir="rtl"></span>)<font size="2"><font face="B Mitra"><span style="mso-spacerun: yes"> </span>و ترومبوآمبولی ریوی (</font></font></span><span style="font-family: "Times New Roman","serif" font-size: 9pt mso-bidi-language: FA mso-bidi-font-size: 10.0pt mso-bidi-font-family: "B Mitra"" dir="ltr">PTE= Pulmonary
Thromboembolism</span><span dir="rtl"></span><span lang="FA" style="font-family: "B Mitra" font-size: 10pt mso-bidi-language: FA mso-ascii-font-family: "Times New Roman" mso-hansi-font-family: "Times New Roman" mso-ansi-font-size: 9.0pt"><span dir="rtl"></span>)
موجب عوارض و افزایش مدت بستری و هزینه های درمان می شود. از آنجا که پروفیلاکسی
باعث کاهش ریسک ایجاد </span><span style="font-family: "Times New Roman","serif" font-size: 9pt mso-bidi-language: FA mso-bidi-font-size: 10.0pt mso-bidi-font-family: "B Mitra"" dir="ltr">DVT</span><span dir="rtl"></span><span lang="FA" style="font-family: "B Mitra" font-size: 10pt mso-bidi-language: FA mso-ascii-font-family: "Times New Roman" mso-hansi-font-family: "Times New Roman" mso-ansi-font-size: 9.0pt"><span dir="rtl"></span> و به دنبال آن </span><span style="font-family: "Times New Roman","serif" font-size: 9pt mso-bidi-language: FA mso-bidi-font-size: 10.0pt mso-bidi-font-family: "B Mitra"" dir="ltr">PTE</span><span dir="rtl"></span><span lang="FA" style="font-family: "B Mitra" font-size: 10pt mso-bidi-language: FA mso-ascii-font-family: "Times New Roman" mso-hansi-font-family: "Times New Roman" mso-ansi-font-size: 9.0pt"><span dir="rtl"></span> می شود ،در این مطالعه بر آن شدیم تا
درصد فراوانی استفاده از پروفیلاکسی علیه </span><span style="font-family: "Times New Roman","serif" font-size: 9pt mso-bidi-language: FA mso-bidi-font-size: 10.0pt mso-bidi-font-family: "B Mitra"" dir="ltr">DVT</span><span dir="rtl"></span><span lang="FA" style="font-family: "B Mitra" font-size: 10pt mso-bidi-language: FA mso-ascii-font-family: "Times New Roman" mso-hansi-font-family: "Times New Roman" mso-ansi-font-size: 9.0pt"><span dir="rtl"></span> در بیماران بستری یکی از بیمارستان
های آموزشی را تعیین نمائیم.<o:p /></span></p><font face="Times New Roman" size="3"> </font><p class="MsoNormal" style="margin: 0in 0in 0pt text-align: justify line-height: normal unicode-bidi: embed direction: rtl text-justify: kashida text-kashida: 0%" dir="rtl"><b><span lang="FA" style="font-family: "B Mitra" font-size: 10pt mso-bidi-language: FA mso-ascii-font-family: "Times New Roman" mso-hansi-font-family: "Times New Roman" mso-ansi-font-size: 9.0pt">روش کار</span></b><span dir="ltr"></span><b><span style="font-family: "Times New Roman","serif" font-size: 9pt mso-bidi-language: FA mso-bidi-font-size: 10.0pt mso-bidi-font-family: "B Mitra"" dir="ltr"><span dir="ltr"></span>:</span></b><span dir="rtl"></span><span lang="FA" style="font-family: "B Mitra" font-size: 10pt mso-bidi-language: FA mso-ascii-font-family: "Times New Roman" mso-hansi-font-family: "Times New Roman" mso-ansi-font-size: 9.0pt"><span dir="rtl"></span> در یک پژوهش توصیفی گذشته نگر تعداد 202
بیمار ازافراد بستری در بخشهای جراحی بیمارستان به صورت تصادفی انتخاب و طبقه بندی
شده<font size="2"><font face="B Mitra"><span style="mso-spacerun: yes"> </span>و سپس اطلاعات بر اساس متغیرهای موجود
و چک لیستی که بر اساس اهداف مطالعه طراحی شده بود ،از پرونده بیماران استخراج و
درصد فراوانی استفاده از پروفیلاکسی برعلیه ترومبوز وریدهای عمقی محاسبه شد. </font></font></span><span style="font-family: "Times New Roman","serif" font-size: 9pt mso-bidi-language: FA mso-bidi-font-size: 10.0pt mso-bidi-font-family: "B Mitra"" dir="ltr"><o:p /></span></p><font face="Times New Roman" size="3"> </font><p class="MsoNormal" style="margin: 0in 0in 0pt text-align: justify line-height: normal unicode-bidi: embed direction: rtl text-justify: kashida text-kashida: 0%" dir="rtl"><b><span lang="FA" style="font-family: "B Mitra" font-size: 10pt mso-bidi-language: FA mso-ascii-font-family: "Times New Roman" mso-hansi-font-family: "Times New Roman" mso-ansi-font-size: 9.0pt">نتیجه:</span></b><span lang="FA" style="font-family: "B Mitra" font-size: 10pt mso-bidi-language: FA mso-ascii-font-family: "Times New Roman" mso-hansi-font-family: "Times New Roman" mso-ansi-font-size: 9.0pt"> (52%) 105 نفر مرد و (48%) 97 نفر زن بودند که (7/30%) 62
نفر از بخش جراحی، (7/25%) 52 نفر از بخش ارتوپدی، (8/17%) 36 نفر از بخش زنان، (
3/16%) 33 نفر از بخش جراحی اعصاب و (4/9%) 19 نفر از بخش کلیه و مجاری ادراری
بوده اند.<o:p /></span></p><font face="Times New Roman" size="3"> </font><p class="MsoNormal" style="margin: 0in 0in 0pt text-align: justify line-height: normal unicode-bidi: embed direction: rtl text-justify: kashida text-kashida: 0%" dir="rtl"><span lang="FA" style="font-family: "B Mitra" font-size: 10pt mso-bidi-language: FA mso-ascii-font-family: "Times New Roman" mso-hansi-font-family: "Times New Roman" mso-ansi-font-size: 9.0pt">114 نفر (%43/56)
پروفیلاکسی گرفتند که 13 نفر در گروه ریسک بالا،10 نفر در گروه ریسک متوسط و 91
نفر در گروه با ریسک پائین بودند و 88 نفر (%56/43) از بیماران هم پروفیلاکسی
دریافت نکرده اند. <o:p /></span></p><font face="Times New Roman" size="3"> </font><p class="MsoNormal" style="margin: 0in 0in 0pt text-align: justify line-height: normal unicode-bidi: embed direction: rtl text-justify: kashida text-kashida: 0%" dir="rtl"><b><span lang="FA" style="font-family: "B Mitra" font-size: 10pt mso-bidi-language: FA mso-ascii-font-family: "Times New Roman" mso-hansi-font-family: "Times New Roman" mso-ansi-font-size: 9.0pt">بحث:</span></b><span lang="FA" style="font-family: "B Mitra" font-size: 10pt mso-bidi-language: FA mso-ascii-font-family: "Times New Roman" mso-hansi-font-family: "Times New Roman" mso-ansi-font-size: 9.0pt"> در مطالعه ما میزان لازم پروفیلاکسی صحیح در حدود 3/24%
برآورد شده که در حد بررسیهای انجام شده در سایر مطالعات میباشد. در جمعیتهایی
که سن بالا دارند و در معرض خطر بیشتری هستند باید از روش</span><span dir="ltr"></span><span lang="FA" style="font-family: "Times New Roman","serif" font-size: 9pt mso-bidi-language: FA mso-bidi-font-size: 10.0pt mso-bidi-font-family: "B Mitra"" dir="ltr"><span dir="ltr"></span> </span><span lang="FA" style="font-family: "B Mitra" font-size: 10pt mso-bidi-language: FA mso-ascii-font-family: "Times New Roman" mso-hansi-font-family: "Times New Roman" mso-ansi-font-size: 9.0pt">های پروفیلاکسی
صحیح تر استفاده شود. در مطالعه ما فقط 14% در گروه ریسک بالا بودند و با توجه به
نیاز جدی به پروفیلاکسی علیه </span><span style="font-family: "Times New Roman","serif" font-size: 9pt mso-bidi-language: FA mso-bidi-font-size: 10.0pt mso-bidi-font-family: "B Mitra"" dir="ltr">DVT</span><span dir="rtl"></span><span lang="FA" style="font-family: "B Mitra" font-size: 10pt mso-bidi-language: FA mso-ascii-font-family: "Times New Roman" mso-hansi-font-family: "Times New Roman" mso-ansi-font-size: 9.0pt"><span dir="rtl"></span> در این گروه توصیه می شود مطالعه روی
گروه</span><span dir="ltr"></span><span lang="FA" style="font-family: "Times New Roman","serif" font-size: 9pt mso-bidi-language: FA mso-bidi-font-size: 10.0pt mso-bidi-font-family: "B Mitra"" dir="ltr"><span dir="ltr"></span> </span><span lang="FA" style="font-family: "B Mitra" font-size: 10pt mso-bidi-language: FA mso-ascii-font-family: "Times New Roman" mso-hansi-font-family: "Times New Roman" mso-ansi-font-size: 9.0pt">های با ریسک بالا صورت گیرد.<o:p /></span></p><font face="Times New Roman" size="3"> </font>
<font face="Times New Roman" size="3"> </font><p class="MsoNormal" style="margin: 0in 0in 0pt text-align: justify line-height: normal vertical-align: top text-justify: kashida text-kashida: 0%"><b><span style="font-family: "Times New Roman","serif" mso-ascii-theme-font: major-bidi mso-hansi-theme-font: major-bidi mso-bidi-theme-font: major-bidi mso-bidi-language: FA"><font size="3">Background</font></span></b><span style="font-family: "Times New Roman","serif" mso-ascii-theme-font: major-bidi mso-hansi-theme-font: major-bidi mso-bidi-theme-font: major-bidi mso-bidi-language: FA"><font size="3">: Misdiagnosis and treatment of Deep Vein
Thrombosis (DVT) and Pulmonary Thromboembolism (PTE) usually cause some
problems and also lengthen the hospitalization period and treatment costs.<span style="mso-spacerun: yes"><font face="Times New Roman"> </font></span>Prophylaxis often reduces the risk of DVT and
following PTE, therefore in this study we aimed to determine the frequency of
using Prophylaxis to prevent DVTs in Rasoul Akram hospital in <st1:place w:st="on"><st1:city w:st="on">Tehran</st1:city>, <st1:country-region w:st="on">Iran</st1:country-region></st1:place></font><font size="3">.<o:p /></font></span></p><font face="Times New Roman" size="3"> </font><p class="MsoNormal" style="margin: 0in 0in 0pt text-align: justify line-height: normal vertical-align: top text-justify: kashida text-kashida: 0%"><b><span style="font-family: "Times New Roman","serif" mso-ascii-theme-font: major-bidi mso-hansi-theme-font: major-bidi mso-bidi-theme-font: major-bidi mso-bidi-language: FA"><font size="3">Methods:</font></span></b><span style="font-family: "Times New Roman","serif" mso-ascii-theme-font: major-bidi mso-hansi-theme-font: major-bidi mso-bidi-theme-font: major-bidi mso-bidi-language: FA"><font size="3"> In this Retrospective descriptive study, 202
participants were chosen from the patients admitted for surgery in the surgery
unites and randomly stratified and classified.<span style="mso-spacerun: yes"><font face="Times New Roman"> </font></span></font><font size="3">Information was extracted for these participants, based on variables and
the objectives of this study and after that the frequency of using prophylaxis
to prevent DVT was calculated by using descriptive analysis tool.<o:p /></font></span></p><font face="Times New Roman" size="3"> </font><p class="MsoNormal" style="margin: 0in 0in 0pt text-align: justify line-height: normal vertical-align: top text-justify: kashida text-kashida: 0%"><b><span style="font-family: "Times New Roman","serif" mso-ascii-theme-font: major-bidi mso-hansi-theme-font: major-bidi mso-bidi-theme-font: major-bidi mso-bidi-language: FA"><font size="3">Results: </font></span></b><span style="font-family: "Times New Roman","serif" mso-ascii-theme-font: major-bidi mso-hansi-theme-font: major-bidi mso-bidi-theme-font: major-bidi mso-bidi-language: FA"><font size="3">Our study consisted of 105 male (%52) and 97
female (%48) patients in which 62(%30.7) were from surgery unite, 52(%25.7)
orthopedic , 36( %17.8) Gynecology, 33(%16.3) neurosurgery<span style="mso-spacerun: yes"><font face="Times New Roman"> </font></span></font><font size="3">and 19(%9.4) urology. 114(%56.43) of
participants received prophylaxis versus 88 (%43.56) the patients did not
receive prophylaxis. 13 in high risk groups, 10 in the moderate risk group and
91 were in low-risk group.<o:p /></font></span></p><font face="Times New Roman" size="3"> </font><p class="MsoNormal" style="margin: 0in 0in 0pt text-align: justify line-height: normal vertical-align: top text-justify: kashida text-kashida: 0%"><font size="3"><b><span style="font-family: "Times New Roman","serif" mso-ascii-theme-font: major-bidi mso-hansi-theme-font: major-bidi mso-bidi-theme-font: major-bidi mso-bidi-language: FA">Conclusion:</span></b><span style="font-family: "Times New Roman","serif" mso-ascii-theme-font: major-bidi mso-hansi-theme-font: major-bidi mso-bidi-theme-font: major-bidi mso-bidi-language: FA"> In our study, the correct usage of
prophylaxis was in %24.3 of incidents, which was consistent with previous
studies. In older populations who are subject to more risks in treatment, it is
very important to employ more precise prophylaxis treatments. In this study
only %14 of participants were from high risk group. Regarding the serious need
for prophylaxis to prevent DVT in this particular population, the expansion of
our studies toward those populations in higher risks is absolutely
suggested.<font face="Times New Roman"><span style="mso-spacerun: yes"> </span><o:p /></font></span></font></p><font face="Times New Roman" size="3"> </font>
ترومبوز وریدی عمقی، پروفیلاکسی، ترومبوآمبولی ریوی، پیشگیری.
Pulmonary Thromboembolism, Deep Vein Thrombosis, Prophylaxis, Prevention.
77
82
http://rjms.iums.ac.ir/browse.php?a_code=A-10-1-1380&slc_lang=fa&sid=1
Morteza
Khavaninzadeh
مرتضی
خوانین زاده
3900319475328460022538
3900319475328460022538
Yes
Tehran University of Medical Sciences
دانشگاه علوم پزشکی تهران
Seyyed Saber
Mousavi Vaeezi
سید صابر
موسوی واعظی
3900319475328460022539
3900319475328460022539
No
Ehsan
Ramezaniyan Nik
احسان
رمضانیان نیک
3900319475328460022540
3900319475328460022540
No
Kobra
Reza Gharebagh
کبری
رضا قره باغ
3900319475328460022541
3900319475328460022541
No
Tehran University of Medical Sciences
دانشگاه علوم پزشکی تهران